Shanmuga Hospital share price, P/E, ROE & financials

As of 6 Nov 2026, Shanmuga Hospital trades at 14.5× trailing earnings, below the industry P/E of 47.7×, and the shares are 21% below their 52-week high. It earns ROCE of 13% and ROE of 10%, and sales grew 6.4% a year over 3 years while net profit fell 4.0%. Debt is 0.16× equity. It is listed on an SME platform with a market cap of ₹61 Cr, ranked 31st of 40 Medical Care Facilities companies by market cap; the shares rose 1.2% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year

Open: ₹45.10
Day high: ₹45.10
Day low: ₹45.00
Prev. close: ₹45.00
Volume: 4K

Health check

3 good · 2 fair · 1 to check

ReturnsIn line
+1.2% over a year, better than 3 of 7 peers.
Price tagCheaper
P/E 14.5 vs industry 47.7.
GrowthSlow
Sales +6.4%, profit −4.0% a year over 3 years.
ProfitabilityAverage
ROCE 12.7% vs peer median 11.9%.
Balance sheetSolid
Debt 0.16× equity, interest covered 16.4×, Piotroski 6 of 9.
Red flagsNone found
No warning signs in the headline numbers.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Small cap

₹61 Cr, #31 of 40 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹48 Cr · profit ₹4 Cr

Market cap: ₹61 Cr; Small cap
P/E: 14.5; Industry 47.7
Price to book: 1.45; Peers 8.06
Dividend yield: 0.00%
ROE: 10.2%; Peers 12.8%
ROCE: 12.7%; Peers 11.9%
Debt to equity: 0.16; Debt ₹6.74 Cr
EPS (TTM): ₹3.11
OPM (TTM): 11.7%; Net margin 8.8%
Sales growth: +3.4%; Latest quarter vs a year ago
Profit growth: +3.9%; Latest quarter vs a year ago
Price to sales: 1.27; EV/EBITDA 7.3

Strengths

P/E of 14.5 against an industry P/E of 47.7.

No obvious red flags in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Shanmuga Hospital

Shanmuga Hospital Limited operates a multispecialty hospital in Tamil Nadu. The company offers inpatient and outpatient care across various advanced robotic surgery, oncology, surgical and medical oncology, radiation oncology, general surgery and gastroenterology, orthopedics and rheumatology, cardiology, general medicine and geriatrics, pediatrics and neonatology, obstetrics and gynecology, neurology, nephrology, urology, psychiatry, radiology,…

Headquarters: Salem
Employees: 254
Sector: Healthcare
ISIN: INE0TD301017
Website: shanmugahospital.com

Price range

52 weeks

₹34.00₹56.76

Today

₹45.00₹45.10

Avg volume (3M): 11.7K
1-year return: plus 1.2%
From 52-week high: minus 20.7%

Peers · Medical Care Facilities

Compare with peers Screen the whole industry

Company
APOLLOHOSPApollo Hospitals Enterprise	8,446.00	plus 0.90%	1,21,441	54.0	11.45	19.2%	22.5%	15.4%	14.8%	33.3%	0.24%	plus 7.2%
MAXHEALTHMax Healthcare Institute	934.00	plus 0.21%	90,909	66.1	8.03	12.6%	12.8%	26.8%	22.4%	9.3%	0.21%	minus 18.1%
MANIPALHOSManipal Health Enterprises	646.70	minus 1.61%	85,065	133.6	9.05	9.8%	9.2%	17.8%	–	–	0.00%	minus 3.0%
ASTERDMAster DM Quality Care	713.15	minus 0.89%	62,092	90.7	8.06	9.4%	9.7%	17.4%	15.7%	−3.0%	0.42%	plus 4.5%
FORTISFortis Healthcare	766.90	minus 6.45%	57,898	55.7	5.52	11.9%	10.4%	22.2%	13.3%	20.9%	0.13%	minus 19.6%
NHNarayana Hrudayalaya	1,903.00	minus 0.65%	38,650	44.7	7.73	11.4%	19.1%	18.5%	20.5%	9.9%	0.24%	plus 4.7%
MEDANTAGlobal Health	1,387.60	minus 0.15%	37,264	60.4	8.63	15.0%	15.2%	22.1%	17.2%	19.5%	0.04%	plus 11.2%
SHANMUGAShanmuga Hospital	45.00	0.00%	61	14.5	1.45	12.7%	10.2%	11.7%	6.4%	−4.0%	0.00%	plus 1.2%
Median of 7 peers	–	−0.65%	62,092	60.4	8.06	11.9%	12.8%	18.5%	16.5%	14.7%	0.21%	4.5%

Quarterly results

Consolidated, ₹ crore

SalesSelect a row below to chart it

Jun 25	Sep 25	Jun 26
11.5	13.1	11.9
9.4	10.7	9.8
2.1	2.4	2.1
18.3%	18.6%	17.7%
0.1	0	0
0.1	0.1	0.1
0.8	0.9	0.7
1.3	1.4	1.3
26.9%	24.4%	25.0%
0.9	1.1	1
0.70	–	0.72

Dec 25, Mar 26 not reported by the data source.

Profit & loss

Yearly, ₹ crore

Sales CAGR 3Y: +6.4%
Profit CAGR 3Y: −4.0%
EPS CAGR 3Y: −4.1%
ROE: 10.2%

Net profitSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
39.3	43	47.9	47.4
–	+9.4%	+11.2%	minus 0.9%
32.1	34.4	39.6	39.2
7.3	8.6	8.2	8.3
18.5%	20.0%	17.2%	17.5%
0.1	0.3	0.2	0.6
0.3	0.5	0.6	0.4
0.6	1.3	2.2	2.8
–	−0	–	–
6.6	7	5.7	5.7
27.6%	25.3%	26.0%	25.7%
4.8	5.2	4.2	4.2
–	+10.2%	minus 19.8%	+0.1%
3.50	3.86	4.03	3.09

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore

Total assetsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
0.1	9.8	13.6	13.6
11.7	7.3	26.1	28.9
7.6	9	7.6	6.7
3.6	7.8	5.5	3.8
23	33.9	52.8	53.1
10	20.2	22.4	39.9
–	4.3	–	2.4
0.1	0.1	0.1	0.1
3.2	2.1	12.6	1.9
9.8	7.2	17.7	8.7
23	33.9	52.8	53.1

Cash flow

Yearly, ₹ crore

Cash from operationsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
2.9	9.6	−1.6	12.3
−8.3	−11.6	−4.3	−20.3
7.4	0.9	16.4	−2.7
2	−1.1	10.5	−10.7
−8.3	−11.5	−4.4	−20.5
−5.3	−1.9	−6	−8.2

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you